DEUTSCHE BANK AG\
BankPosition in HRTX — Heron Therapeutics, Inc. /De/
CIK 948046
FRANKFURT AM MAIN, 2M
Position in HRTX
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$41,409
-$33,055 QoQ
Shares Held
96,300
+3.5% QoQ
Ownership
0.051%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#60
of 160 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in HRTX Over Time
Shares Held
Position Value (USD)
Derivatives in HRTX
reported options exposure · as of Mar 31, 2021CallValue
$8,429
CallShares
520
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026DEUTSCHE BANK AG\ holds $3,190,028,280 across 296 Biotechnology names. HRTX ranks #287 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,579,110 | $784,391,303 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
518,409 | $323,248,743 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
815,400 | $245,459,858 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
888,019 | $166,308,196 | |
| 5 | RPRX |
Royalty Pharma plc
|
2,717,951 | $152,395,510 | |
| 6 | INCY |
Incyte Corp
|
1,262,988 | $143,172,312 | |
| 7 | ARGX |
Argenx SE
|
137,335 | $127,415,291 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
249,611 | $78,899,539 |
All Filings in HRTX
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $41,409 | 96,300 | Shares | Defined | 2026-08-07 | |
| 2026-03-31 | $74,464 | 93,081 | Shares | Defined | 2026-05-06 | |
| 2025-12-31 | $121,005 | 93,081 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $107,299 | 85,158 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $140,199 | 67,729 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $188,342 | 85,610 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $91,472 | 59,786 | Shares | Defined | 2025-06-30 | |
| 2024-09-30 | $118,974 | 59,786 | Shares | Defined | 2025-06-26 | |
| 2024-06-30 | $109,606 | 31,316 | Shares | Defined | 2025-06-12 | |
| 2024-03-31 | $121,505 | 43,865 | Shares | Defined | 2025-06-02 | |
| 2023-12-31 | $77,435 | 45,551 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $46,916 | 45,551 | Shares | Defined | 2023-11-24 | |
| 2023-06-30 | $52,838 | 45,551 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $101,379 | 67,139 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $126,780 | 50,712 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $211,096 | 50,023 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $153,914 | 55,167 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $1,110,221 | 194,095 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $3,548,190 | 388,630 | Shares | Defined | 2022-02-16 | |
| 2021-09-30 | $5,658,642 | 529,340 | Shares | Defined | 2021-11-04 | |
| 2021-06-30 | $8,081,030 | 520,685 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $8,429 | 520 | Call | Defined | 2021-05-13 | |
| 2021-03-31 | $6,785,554 | 418,603 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $14,635,412 | 691,328 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $9,000,199 | 607,301 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $8,726,573 | 593,241 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $4,941,962 | 420,951 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||